EMEA-000968-PIP02-11-M05

Key facts

Invented name
Vitekta
Active substance
elvitegravir
Therapeutic area
Infectious diseases
Decision number
P/0274/2016
PIP number
EMEA-000968-PIP02-11-M05
Pharmaceutical form(s)
  • Film coated tablet
  • Dispersible tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
Gilead Sciences International Ltd

Tel. +44 (0)1223 897300
E-mail: regulatory.pip@gilead.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating